Synthesis and antitumor activity of the immunoconjugate BR96-Dox
- 8 March 1999
- journal article
- Published by Elsevier
- Vol. 39 (2-3) , 251-259
- https://doi.org/10.1016/0168-3659(95)00160-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Orthotopic is orthodox: Why are orthotopic‐transplant metastatic models different from all other models?Journal of Cellular Biochemistry, 1994
- (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicinBioconjugate Chemistry, 1993
- Cure of Xenografted Human Carcinomas by BR96-Doxorubicin ImmunoconjugatesScience, 1993
- Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5‐fluorouracilInternational Journal of Cancer, 1992
- Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activityCancer Immunology, Immunotherapy, 1991
- New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicityBioconjugate Chemistry, 1991
- Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spreadInternational Journal of Cancer, 1991